Abstract
Oxidative stress is common in inflammatory processes associated with many diseases including Chagas' disease. The aim of the present study was to evaluate, in a murine model, biomarkers of oxidative stress together with components of the antioxidant system in order to provide an overview of the mechanism of action of the iron chelator desferrioxamine (DFO). The study population comprised 48 male Swiss mice, half of which were treated daily by intraperitoneal injection of DFO over a 35-day period, while half were administered sterile water in a similar manner. On the 14th day of the experiment, 12 DFO-treated mice and an equal number of untreated mice were experimentally infected with Trypanosoma cruzi. Serum concentrations of nitric oxide and superoxide dismutase and hepatic levels of total glutathione, thiobarbituric acid reactive species and protein carbonyl, were determined on days 0, 7, 14 and 21 post-infection. The results obtained revealed that DFO enhances antioxidant activity in the host but also increases oxidative stress, indicating that the mode of action of the drug involves a positive contribution to the host together with an effect that is not beneficial to the parasite.
Keywords: DESFERRIOXAMINE, OXIDATIVE STRESS, CHAGAS' DISEASE, TRYPANOSOMA CRUZI
Full Text
The Full Text of this article is available as a PDF (170.9 KB).
References
- 1.Gupta S, Wen JJ, Garg NJ. Oxidative stress in Chagas' Disease. Interdiscip Perspect Infect Dis 2009; 2009: 190354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pedrosa ML, Silva ME, Silva ME, Silva MEC, Nicoli JR, Vieira EC. The effect of iron deficiency and iron overload on the evolution of Chagas' disease produced by three strains of Trypanosoma cruzi in CFW mice. Comp Biochem Physiol A 1990; 97: 235–243. [DOI] [PubMed] [Google Scholar]
- 3.De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 1995; 21 (Suppl. 2): S162-S165. [DOI] [PubMed] [Google Scholar]
- 4.Bécuwe P, Gratepanche S, Fourmaux MN et al. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium fakiparum. Mol Biochem Parasitol 1996; 76: 125-134. [DOI] [PubMed] [Google Scholar]
- 5.Zannineli G, Glickstein H, Breuer W, Brissot P, Hider RC, Cabantchik ZI. Chelation and mobilization of cellular iron by different classes of chelators. Mol Pharmaco11997; 51: 842-852. [DOI] [PubMed] [Google Scholar]
- 6.Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematol Am Soc Hematol Educ Program 2001; 1: 47–61. [DOI] [PubMed] [Google Scholar]
- 7.Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 1964; 119: 758–768. [DOI] [PubMed] [Google Scholar]
- 8.Arantes JM, Pedrosa ML, Martins HR et al. Trypanosoma cruzi: treatment with the iron chelator desferrioxamine reduces parasitemia and mortality in experimentally infected mice. Exp Parasitol 2007; 117: 43–50. [DOI] [PubMed] [Google Scholar]
- 9.Francisco AF, Vieira PMA, Arantes JM et al. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice. Exp Parasitol 2008; 120: 314–319. [DOI] [PubMed] [Google Scholar]
- 10.Lalonde RG, Holbein BE. Role of iron in Trypanosoma cruzi infection of mice. J Clin Invest 1984; 3: 470–476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Loo VG, Lalonde RG. Role of iron in intracellular growth of Trypanosoma cruzi. Infect Immun 1984; 45: 726–730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Silva LHP, Nussenzweig V. Sobre uma cepa altamente virulenta para o camundongo branco. Folia Clin Biol 1953; 20: 191–203. [Google Scholar]
- 13.Filardi LS, Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas' Disease. Trans R Soc Trop Med Hyg 1987; 81: 755–759. [DOI] [PubMed] [Google Scholar]
- 14.Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478. [DOI] [PubMed] [Google Scholar]
- 15.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275. [PubMed] [Google Scholar]
- 16.Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302–310. [DOI] [PubMed] [Google Scholar]
- 17.Green LC, Wagner DA, Gloglowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and (“N)-nitrate in biological fluids. Anal Biochem 1982; 126: 131–138. [DOI] [PubMed] [Google Scholar]
- 18.MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immuno11997; 5: 323-350. [DOI] [PubMed] [Google Scholar]
- 19.Philipp S, Cui L, Ludolph B, Kelm M, Schulz R, Cohen MV, Downey JM. Desferoxamine and ethyl-3,4-dihydroxybenzoate protect myocardium by activating noxidative stress and generating mitochondrial ROS. Am J Physiol 2006; 290: H450–H457. [DOI] [PubMed] [Google Scholar]
- 20.Pérez-Fuentes R, Torres-Rasgado E, Salgado-Rosas H, Zamora-Ginez I, Sánchez-Guillén MC. The anti-oxidant defence response in individuals with the indeterminate form of Chagas' disease (American trypanosomiasis). Ann Trop Med Parasitol 2008; 102: 189–197. [DOI] [PubMed] [Google Scholar]
- 21.De Oliveira TB, Pedrosa RC, Wilhelm Filho D. Oxidative stress in chronic cardiopathy associated with Chagas' disease. Int J Cardiol 2007; 116: 357–363. [DOI] [PubMed] [Google Scholar]
- 22.Fairlamb AH, Cerami A. Metabolism and functions of trypanothione in the kinetoplastida. Annu Rev Microbiol 1992; 46: 695–729. [DOI] [PubMed] [Google Scholar]